Product Program year 2025 Source: CMS Open Payments

Venovo

Device Vascular/Oncology

PDI 00801741103964

Open in the dashboard

General payments

$186,287

3,177 payments

Research payments

$0

0 payments

Through program year 2025, $186,287 in general payments and $0 in research payments were reported against Venovo (Vascular/Oncology).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

4 rows
Year Kind Amount Payments
2025 General $61,785 1,061
2024 General $49,593 956
2023 General $74,895 1,159
2022 General $15 1

Breakdown

Who paid General payments · program years 2022–2025
  1. Bard Peripheral Vascular, Inc. $166,935 2,757 payments
  2. Becton, Dickinson and Company $17,452 385 payments
  3. Davol Inc. $1,842 31 payments
  4. C. R. Bard, Inc. & Subsidiaries $58 4 payments
Top recipients General payments · program year 2025
  1. Ramesh Gowda Interventional Cardiology · New York, NY $1,691 3% · 15 payments
  2. Matthew Tiede Diagnostic Radiology · Wyoming, MI $1,299 2% · 8 payments
  3. Adam Guyer Vascular & Interventional Radiology · Salem, VA $1,211 2% · 2 payments
  4. Rema Malik Vascular Surgery · Houston, TX $956 2% · 3 payments
  5. Elsie Koh Vascular & Interventional Radiology · Woodland Park, NJ $871 1% · 10 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Vascular & Interventional Radiology Radiology $13,570 22% · 156 practitioners
  2. Vascular Surgery Surgery $10,427 17% · 124 practitioners
  3. Interventional Cardiology Internal Medicine $7,941 13% · 50 practitioners
  4. Diagnostic Radiology Radiology $5,497 9% · 57 practitioners
  5. Surgery $3,743 6% · 45 practitioners

The top 5 of 50 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. New York $7,364 12% · 57 recipients
  2. Michigan $6,856 11% · 72 recipients
  3. Florida $5,852 9% · 71 recipients
  4. California $5,405 9% · 62 recipients
  5. Texas $4,428 7% · 45 recipients

The top 5 of 43 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

3,177 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record